---
figid: PMC9374466__IJO-61-3-05400-g07
pmcid: PMC9374466
image_filename: IJO-61-3-05400-g07.jpg
figure_link: /pmc/articles/PMC9374466/figure/f8-ijo-61-3-05400/
number: Figure 8
figure_title: ''
caption: PBAE/si-CASC11 nanocomplexes may inhibit the progression of prostate cancer.
  (A-C) Weight and volume changes following 3 weeks of xenograft tumor treatment with
  saline, si-CASC11 or PBAE/si-CASC11. (D and E) Expression levels of Ki-67 were detected
  by immunohistochemistry. Scale bars, 100 and 200 µm. **P<0.01 vs. saline group or
  as indicated. CASC11, cancer susceptibility candidate 11; PBAE, poly (β-amino ester);
  si, small interfering.
article_title: Long non-coding RNA CASC11 interacts with YBX1 to promote prostate
  cancer progression by suppressing the p53 pathway.
citation: Xianchao Sun, et al. Int J Oncol. 2022 Sep;61(3):110.
year: '2022'

doi: 10.3892/ijo.2022.5400
journal_title: International Journal of Oncology
journal_nlm_ta: Int J Oncol
publisher_name: D.A. Spandidos

keywords:
- prostate cancer
- CASC11
- Y-box binding protein 1
- p53 pathway
- progression

---
